Gene Therapy Restores Protein Expression in Cone Photoreceptors in Rpe65R91W/R91W Mice
Author Information
Author(s): Kostic Corinne, Crippa Sylvain Vincent, Pignat Vérène, Bemelmans Alexis-Pierre, Samardzija Marijana, Grimm Christian, Wenzel Andreas, Arsenijevic Yvan
Primary Institution: Jules-Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland
Hypothesis
Can gene therapy effectively restore cone photoreceptor function in Rpe65R91W/R91W mice?
Conclusion
Gene therapy using RPE65 can not only halt cone degeneration but also restore protein expression in cones that were previously affected.
Supporting Evidence
- Gene therapy improved the expression of cone-specific proteins in treated mice.
- Treatment at postnatal day 5 showed significant cone preservation compared to untreated mice.
- Gene transfer at 1 month of age still allowed for some cone rehabilitation.
Takeaway
Scientists found a way to help sick eye cells get better by giving them a special treatment, which helps them work like they should again.
Methodology
The study involved subretinal injections of a lentiviral vector to deliver the RPE65 gene to Rpe65R91W/R91W mice at different ages and assessed the effects on cone function and protein expression.
Limitations
The study did not demonstrate functional recovery of cone photoreceptors despite restoration of protein expression.
Participant Demographics
Rpe65R91W/R91W mice, a model for early-onset retinal degeneration.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website